MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within a short open reading frame of the 12S rRNA (MT-RNR1) region of mitochondrial DNA. It is studied as an energy-sensing regulator acting through the AMPK (Thr172) node. This product is supplied as a lyophilized research-grade peptide for in vitro and preclinical laboratory investigation only.
| Full name | Mitochondrial ORF of the 12S rRNA type-c (MOTS-c) |
| Sequence | MRWQEMGYIFYPRKLR (16 aa) |
| Residues | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| Molecular formula | C101H152N28O22S2 |
| Molecular weight | 2174.6 Da |
| Encoded by | mtDNA — 12S rRNA (MT-RNR1) sORF |
| Peptide class | Mitochondrial-derived peptide (MDP) |
| Primary node | AMPK (Thr172) energy sensing |
| Discovery | Lee et al., 2015 · USC · Cell Metabolism |
Investigational directions enabled by the published mechanism — not therapeutic claims.
- ◆AMPK (Thr172) activation and downstream metabolic signaling
- ◆GLUT4 translocation and insulin-independent glucose uptake models
- ◆mTORC1 restraint and PGC-1α mitochondrial biogenesis studies
- ◆Metabolic-aging and NRF2/ARE stress-response research
In published models, the folate–purine cycle drives AICAR/ZMP accumulation and activates AMPK at Thr172, promoting GLUT4 translocation while restraining mTORC1. Under metabolic stress, MOTS-c translocates to the nucleus and engages the NRF2/ARE antioxidant program, with PGC-1α and NAD⁺ supporting mitochondrial biogenesis and mitonuclear balance.
Key literature: Lee et al., 2015, Cell Metabolism · Kim et al., 2018, Cell Metabolism · Reynolds et al., 2021, Nature Communications.
| Intended use | Research use only — not approved for human or animal use |
| Authorization | No marketing authorization (investigational MDP) |
| WADA | Not individually named on the Prohibited List |
| Clinical stage | Phase 2a metabolic trial underway (2026) |
- ◆Packaging: 5 × 10 mg lyophilized powder, sterile glass vial
- ◆Storage: Store at 2–8 °C (refrigerated)
- ◆Solubility: Dissolves readily in bacteriostatic water
- ◆Reconstitution: Best used shortly after preparation for optimal stability
- ◆Purity: HPLC-verified ≥ 98% · batch CoA
|
◆ Purity HPLC-verified ≥ 98% with batch CoA |
◆ Evidence Peer-reviewed citations for all mechanistic claims |
◆ Transparency Evidence limitations stated per molecule |
◆ Safety Research use only — not for human or animal consumption |
TFLL Pharma · TFLL BV · Belgium · Life Span · Health Span · Brain Span · www.tfllpharma.com
Related product